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INTRODUCTION
Glaucoma is the leading cause of irreversible blindness worldwide(1,2). 
This disease is associated with chronic and progressive optic neuro-
pathy(1,3) characterized by loss of retinal ganglion cells(3), which leads 
to visual field deterioration(1,3,4). Moreover, glaucoma is associated 
with traffic accidents, restricted mobility, and falls, thus affecting qua -
lity of life(1). An important risk factor for glaucoma is intraocular 
pressure (IOP), and its decrease is the mainstay of treatment(3). 
IOP measurement has been a matter of debate for many years. 
In 1950, Goldmann introduced an approach to measure IOP, which is 
called applanation tonometry, and this approach is currently the gold 
standard(3-5). This approach is related to the elasticity of the cornea, 
which indicates that it depends on corneal thickness and hysteresis(4). 
Goldmann assumed that the average central corneal thickness (CCT) 
would be approximately 500 µm(4-7), and excessively thin and thick 
corneas would cause underestimations and overestimations of the 
IOP, respectively(4,7,8). With the advent of more sophisticated devices 
capable of measuring CCT, it has become clear that CCT is much 
more variable than predicted by Goldmann(5-7). More recently, some 
studies, such as the Ocular Hypertension Treatment Study (OHTS), 
stated that CCT is an important confounder of Goldmann applanation 
tonometer (GAT) measurements(5,6,8). In addition, factors, such as 
astigmatism, examiner’s competence, gaze direction, tear thickness, 
corneal hydration, connective tis sue composition, bioelasticity, 
corneal curvature, and other corneal biomechanical properties, are 
important sources of error in GAT measurements(2-4,8). Currently, an 
accepted formula to correct IOP is not available(4,6,7).
The ocular response analyzer (ORA) was introduced in 2005, and 
it was classified as a non-contact tonometer(2,3,5,9). This tonometer 
allows the measurement and evaluation of corneal biomechanical 
properties, namely corneal hysteresis (CH), corneal resistance factor 
(CRF), and corneal compensated intraocular pressure (IOPcc)(3,5), as 
well as CCT and Goldmann correlated intraocular pressure (IOPg)(3,5). 
Briefly, the ORA produces a rapid air pulse that deforms the corneal 
curvature(2,3,5,9) and records corneal deformation(2,9). When the cornea 
moves inward, it reaches the first applanation state (P1)(2,3,9). After a 
slightly concave state(2,3,9), the air pulse pressure decreases and the 
cornea moves outward, passing through the second applanation 
state (P2)(2,3,9). The average of P1 and P2 is IOPg, which is analogous 
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ABSTRACT
Purpose: Studies have suggested that corneal biomechanical properties influence 
intraocular pressure (IOP) measurements, namely central corneal thickness 
(CCT) and corneal hysteresis (CH). The present study aimed to investigate the 
associations of CH and CCT with glaucoma development.
Methods: We performed a review of the literature and meta-analysis of obser-
vational studies (2006-2016) that included both adult glaucoma patients and 
controls and reported CCT and CH as outcomes. Nineteen studies were conside red 
eligible, and the mean difference (MD) between groups (patient and control) for 
both variables was used for statistical analyses. 
Results: A total of 1,213 glaucoma and 1,055 healthy eyes were studied. Quan-
titative analysis suggested that CH was significantly lower in the glaucoma group 
than in the control group (MD=-1.54 mmHg, 95% CI [-1.68, -1.41], P<0.0001). 
Additionally, CCT was significantly lower in the glaucoma group than in the control 
group (MD=-8.49 µm, 95% CI [-11.36, -5.62], P<0.001). 
Conclusion: Corneal properties appear to differ between glaucoma patients and 
healthy controls. Our results emphasize the importance of corneal biomechanical 
properties in IOP interpretation and should support further studies on the influence 
of CH and CCT in glaucoma screening and diagnosis.
Keywords: Glaucoma; Corneal pachymetry; Cornea/physiopathology; Meta-analysis 
as topic
RESUMO
Objetivo: A literatura sugere que as propriedades biomecânicas da córnea, nomea-
damente a espessura central da córnea (ECC) e a histerese corneana (HC), influenciam 
a medição da pressão intraocular (PIO). Este estudo teve como objetivo investigar a 
associação entre a ECC e a HC e o desenvolvimento de glaucoma. 
Métodos: Revisão da literatura e meta-análise. Foram incluídos estudos observacio-
nais, publicados entre 2006 e 2016, que integrassem um grupo controle e um grupo 
de pacientes com glaucoma em que estes dois grupos apresentassem, igualmente, 
a ECC e a HC como parâmetros. Dezenove estudos foram considerados elegíveis 
e a diferença média (MD) daqueles parâmetros nos dois grupos foi utilizada para 
análise estatística. 
Resultados: Estudaram-se um total de 1.213 olhos com glaucoma e 1.055 olhos 
saudáveis. A análise quantitativa revelou que a HC é significativamente mais baixa 
no grupo de doentes com glaucoma quando comparada com o grupo controle 
(MD=-1,54 mmHg, intervalo de confiança de 95% [-1,68-1,41], P<0,00001). A ECC foi, 
também, significativamente mais baixa no grupo glaucoma quando comparada 
com os indivíduos saudáveis MD=-8,49 µm, intervalo de confiança de 95% [-11,36, 
-5,62], P<0,001). 
Conclusão: Os pacientes com glaucoma parecem possuir propriedades corneanas 
diferentes das que apresentam os indivíduos saudáveis. Os resultados enfatizam a 
importância das propriedades biomecânicas da córnea na interpretação da PIO e 
devem contribuir para novos estudos sobre a influência da HC e da ECC no rastreio e 
diagnóstico do glaucoma. 
Descritores: Glaucoma; Paquimetria corneana; Córnea/fisiopatologia; Meta-análise 
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to the IOP measured by GAT(2,5,9), being the difference between these 
two values (P2 - P1) the value of CH(2,3,5). 
The OHTS revealed that CCT is an important and independent 
risk factor for the development of glaucoma(4-6,10). These results were 
validated in the European Glaucoma Prevention Study (EGPS)(4,5). In 
fact, a two-fold increased risk of progression to glaucoma over 5 
years was found for each 40-mm thinning of the central cornea(4), 
indicating that a patient with a thin cornea has a high risk of glauco-
ma progression(4,6). However, this was not noted in other studies. For 
instance, in the Early Manifest Glaucoma Trial (EMGT), with 5 years of 
follow-up, CCT was not a significant predictive factor for glaucoma 
progression(4). The value of CCT as a significant predictive factor for 
the progression of glaucoma was only noted in patients with high 
baseline IOP and not in those with low baseline IOP after 11 years 
of follow-up(4). Furthermore, other studies such as the Barbados Eye 
Study and the studies by Chauhan et al. and Congdon et al., did not 
find any association between CCT and glaucoma(2,4). 
Interestingly, Congdon et al. showed that CH is associated with 
glaucoma progression risk(2,5,9). This finding suggests that low CH is 
associated with glaucomatous visual field damage and optic nerve 
defects(2,9). In fact, CH may be more strongly associated with glau-
coma diagnosis, risk of progression, and effectiveness of glaucoma 
treatment than CCT itself(2,9).
Nevertheless, the biological link between the biomechanical 
pro perties of the eye and glaucoma development and progression 
remains to be understood(4-6). 
The present study aimed to investigate the associations of CH 
and CCT with glaucoma development. 
METHODS 
Our study is the first review of the literature and meta-analysis 
to collect CCT and CH data from adults with glaucoma and heathy 
controls in order to discuss differences in these two outcomes in 
both groups. This study was conducted in July 2016.
Eligibility critEria
In this study, we only considered observational studies that in-
cluded adult patients with a diagnosis of open-angle glaucoma and 
controls and that reported CCT and CH as outcomes. 
Studies with any other ophthalmologic diagnosis that could 
affect IOP, those not written in English, those with an interventional 
design, those with a non-healthy control group, those with pediatric 
patients and volunteers (age <18 years), and those that did not pro-
vide outcome values for each group separately were excluded.
In order to minimize confounding factors, only studies with 
primary open-angle glaucoma (POAG) were analyzed. Moreover, 
only non-interventional studies were considered to reduce the 
possible interference of procedures and medications with the pri-
mary outcome. 
information sourcEs and sEarch procEdurE
MEDLINE was used as the information source, and the search terms 
used were “hysteresis,” “glaucoma,” and “corneal thickness” between 
January 2006 and July 2016. This limited search period was because 
of the introduction of the ORA, which allows the measurement of 
CH(3), only in 2005(2,9). As CH and CCT were our primary outcomes, 
we used the above-mentioned search terms in order to obtain 
access to a non-restrictive group of studies on this topic for further 
consideration.
study sElEction
A total of 124 articles were identified with the search criteria. The 
abstract from each article was used for screening, and one of the 
abstracts was found to be duplicated. After screening, we found 
45 studies, and of these, 2 were written in French, 2 were written in 
German, 1 was written in Czech, 3 included pediatric populations, 1 
had no outcome information, 2 had a case group with a glaucoma 
diagnosis and other diagnoses, 2 provided data from the control and 
case groups together, 6 had a non-healthy control group, and 7 were 
interventional studies. 
Therefore, for comparative and quantitative purposes, 19 studies 
between 2008 and 2016 were considered (Table 1)(11-29). The study 
selection information is presented in figure 1, according to Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines(30).
data collEction procEss and statistical analysis
The selected full texts were collected and assessed for demographic 
data and reported outcomes. For statistical analysis, we used the mean 
difference (MD) between groups (patient and control) for CH and CCT. 
RESULTS
From a total of 124 studies screened, only 19 complied with our 
eligibility criteria, as shown in figure 1. Table 1 and figures 2 and 3 
summarize the mean and standard deviation (SDs) of both CH and 
CCT for the control and case groups of each study(11-29). 
synthEsis of rEsults
A total of 1,213 glaucoma eyes from 1,159 glaucoma patients and 
1,055 healthy eyes from 1,021 healthy subjects were considered in our 
study. Table 1 shows the baseline characteristics of these participants 
and their eye-related parameters. 
Quantitative analysis showed that CH was significantly lower in 
the glaucoma group than in the control group (MD=-1.54 mmHg, 
95% CI [-1.68, -1.41], p<0.00001; Figure 2). Additionally, CCT was 
significantly lower in the glaucoma group than in the control group 
(MD=-8.49 µm, 95% CI [-11.36 to -5.62], p<0.001; Figure 3). 
DISCUSSION
The latest evidence regarding the true value of CCT as a risk 
factor for glaucoma is still unclear. While some studies have con-
sidered CCT as an important risk factor for the development of 
glau coma(4-6,10), others such as the EMGT, Barbados Eye Study, and 
studies by Chauhan et al. and Congdon et al., did not find a simple 
and linear relationship between CCT and glaucoma(2,4). According 
to our study, there was a significantly lower CCT value among glau-
coma patients than among controls (MD=-8.49 µm, 95% CI [-11.36 
to -5.62], p<0.001). 
The ORA device provides several biomechanical properties that 
are assumed to be less influenced by CCT when compared with GAT 
factors, namely CH, which is a biomechanical property related to the 
viscoelasticity of the cornea. According to our results, there was a sig-
nificantly lower CH among glaucoma patients than among controls 
(MD=-1.54 mmHg, 95% CI [-1.68, -1.41], p<0.00001), and this finding is 
consistent with previous results from other studies(2,9). As the ORA is a 
non-contact tonometer(2,3,5,9), parameters measured using this device 
may be more reliable than those measured using GAT(2,3). 
From these study results, a relevant question that arises invol-
ves the applicability of CH as an instrument in clinical practice and 
its reliability. Standard CCT measurements have been widely used 
and may help interpret IOP findings. However, currently it remains 
undetermined whether this variable per se is useful for assessing a 
patient’s risk for developing glaucoma. In this sense, by providing 
further information about corneal biomechanics, CH may differ from 
CCT. However, there is not enough consolidated evidence to allow 
replacement of CCT with other markers, such as CH, in the mana-
gement of glaucoma patients. The fact that CH is not theoretically 
influenced by CCT(3,5,8,9), which shows large variability in the overall 
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Table 1. Baseline characteristics 
Article Diagnosis No of patients No of eyes
CH CCT
Mean ± SD (mmHg) Mean ± SD (µm)
Kurysheva, 2016(11) Glaucoma 032 032 10.10 ± 1.60 548.10 ± 31.30
Control 030 030 11.20 ± 1.70 549.30 ± 30.80
Pillunat, 2016(12) Glaucoma 048 048 08.54 ± 1.86 530.60 ± 38.40
Control 044 044 10.49 ± 1.67 556.20 ± 37.00
Shin, 2015(13) Glaucoma 097 097 09.90 ± 1.66 548.30 ± 34.82
Control 089 089 10.59 ± 1.71 558.77 ± 31.19
Yazgan, 2014(14) Glaucoma 030 030 06.80 ± 1.70 509.00 ± 36.00
Control 045 045 10.30 ± 1.50 546.30 ± 28.00
Costin, 2014(15) Glaucoma 013 013 09.02 ± 1.52 546.70 ± 35.00
Control 015 015 10.26 ± 1.30 546.10 ± 35.50
Insull, 2010(16) Glaucoma 038 038 08.80 ± 1.52 532.00 ± 33.46
Control 062 062 09.60 ± 1.49 550.00 ± 35.43
Sullivan-Mee, 2012(17) Glaucoma 116 116 07.76 ± 1.60 541.00 ± 36.00
Control 067 067 09.54 ± 1.60 552.00 ± 35.00
Kaushik, 2012(18) Glaucoma 036 036 07.90 ± 2.80 523.50 ± 35.50
Control 071 071 09.50 ± 1.40 530.70 ± 33.40
Detry-Morel, 2012(19) Glaucoma 030 030 09.20 ± 1.10 544.00 ± 37.00
Control 025 025 10.80 ± 1.60 554.00 ± 19 .00
Morita, 2012(20) Glaucoma 083 083 09.20 ± 1.30 535.40 ± 24.90
Control 083 83 10.80 ± 1.30 541.40 ± 26.80
Cankaya, 2011(21) Glaucoma 078 078 06.90 ± 2.10 537.90 ± 35.20
Control 102 102 09.40 ± 1.40 539.80 ± 25.90
Grise-Dulac, 2012(22) Glaucoma 038 075 10.03 ± 2.31 551.50 ± 38.90
Control 022 044 11.05 ± 1.53 550.70 ± 29.30
Detry-Morel, 2011(23) Glaucoma 108 108 09.20 ± 1.60 536.00 ± 61.00
Control 024 024 10.80 ± 1.80 550.00 ± 36.00
Xu, 2011(24) Glaucoma 060 060 09.61 ± 1.56 541.40 ± 37.46
Control 060 060 10.40 ± 1.62 541.75 ± 26.07
Abitbol, 2010(25) Glaucoma 058 058 08.77 ± 1.40 535.34 ± 42.70
Control 075 075 10.46 ± 1.60 560.20 ± 36.30
Mangouritsas, 2009(26) Glaucoma 108 108 08.95 ± 1.27 526.77 ± 35.73
Control 074 074 10.97 ± 1.59 537.84 ± 41.93
Sullivan-Mee, 2008(27) Glaucoma 099 099 08.10 ± 1.50 541.00 ± 41.00
Control 071 071 09.70 ± 1.50 546.00 ± 33.00
Villas-Bôas, 2009(28) Glaucoma 021 038 08.90 ± 2.10 514.80 ± 41.30
Control 012 024 10.20 ± 1.60 529.00 ± 45.40
Beyazyıldız, 2014(29) Glaucoma 066 066 09.10 ± 1.90 550.40 ± 36.30
Control 050 050 09.60 ± 1.70 537.30 ± 38.50
CCT= central corneal thickness; CH= corneal hysteresis; No=number; SD= standard deviation.
population(5-7), is very important. Thus, it can become a valuable tool 
in various assessments, such as assessment of the stratification risk 
of glaucoma patients and even prognosis. However, the ORA is not 
commonly found in ophthalmology clinics worldwide, and this limits 
the knowledge of CH in glaucoma.
The results of our study provide strong evidence on the use of 
CCT and CH. Furthermore, it should be pointed out that this is the first 
review of the literature and meta-analysis on the topic of CH in glau-
coma. However, we recognize that our study has some limitations. 
We included several glaucoma diagnoses (POAG), normal tension 
glaucoma [NTG], pre-perimetric POAG, pseudoexfoliative glaucoma 
[PEXG], and exfoliative glaucoma [EXG]), which could have biased 
the results, as the different physiopathology of each type of glau-
coma may have a different impact on the cornea. Because PubMed 
was used as the search engine, the included papers were limited to 
biomedical literature indexed in the MEDLINE database. Additionally, 
our study only considered articles between 2008 and 2016, according 
to strict criteria. Furthermore, the ORA device was only introduced in 
Gaspar r, et al.
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Figure 1. Study flow diagram.
CI= confidence interval; SD= standard deviation.
Figure 2. Corneal hysteresis - forest plot.
CI= confidence interval; SD= standard deviation.
Figure 3. Central corneal thickness - forest plot. 
Corneal properties and glauComa: a review of the literature and meta‑analysis
206 Arq Bras Oftalmol. 2017;80(3):202-6
2005. Therefore, this study had a relatively short review period. Finally, 
we recognize some other limitations, including the fact that this was 
not a systematic review, risk of bias evaluation was not performed, 
and only observational studies were considered to eliminate the risk 
of bias from interventions. 
In conclusion, this study reveals a significant difference in CH and 
CCT between glaucoma patients and healthy controls. These results 
indicate that there may be better assessments beyond CCT measure-
ment alone. Therefore, it is important to keep searching for new and 
more sophisticated tools to measure corneal properties such as CH 
in order to deepen our knowledge of this subject.
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